Science

Posted by Judith Siers-Poisson on January 30, 2008

The case of Pierre Meneton is fueling demands for legal protections for whistleblowers in France. Meneton is a researcher for the National Institute of Health and the National Institute of Health and Medical Research. He is going to court on January 31, 2008, to face charges of defamation. Several industrial salt producers are suing Meneton for a comment he made during an interview in March 2006. "The lobbying of salt producers and agribusiness is very active.

No
Posted by Judith Siers-Poisson on January 30, 2008

Linda KeenLinda KeenThe fifty-year old nuclear reactor at Chalk River in Ontario, Canada, is running again after the Canadian Parliament overruled the president of the Canadian Nuclear Safety Commission.

No
Posted by Judith Siers-Poisson on January 29, 2008

"The American public deserves to know when someone is trying to persuade them." — U.S. Federal Communications Commissioner Jonathan Adelstein, Thursday, January 17, 2008

Front Groups Beware of Full Frontal Scrutiny

Front Groups - Appearances May Be DeceptiveToday, the Center for Media and Democracy and our partners at Consumer Reports WebWatch launched an exciting new project: Full Frontal Scrutiny. The site seeks to shine a light on front groups -- organizations that state a particular agenda, while hiding or obscuring their identity, membership or sponsorship, or all three. Google the term "front groups" and the number one return is CMD's extensive articles on its SourceWatch site.

Posted by Sheldon Rampton on January 26, 2008

A new report by the Center for Science in the Public Interest (CSPI) suggests that U.S. universities may be jeopardizing their academic integrity by giving oil, gas, and other polluting industries influence over the research that companies fund on campus.

No
Posted by Diane Farsetta on January 23, 2008

The pharmaceutical companies Merck and Schering-Plough, which co-market the cholesterol drug Vytorin, "have gone into damage-control mode, taking out newspaper ads." The PR campaign follows the companies' reluctant publication of a study showing that neither of the drugs present in Vytorin "reduced the buildup of fatty plaque in arteries." The study "was

No
Posted by Sheldon Rampton on January 17, 2008

Cartoon doctorThe pharmaceutical industry is using a novel technique to cheer up people who suffer from clinical depression -- only publishing favorable studies about the effects of its antidepressant medications.

No
Posted by Diane Farsetta on January 15, 2008

"I could not with a clear conscience go into that newsroom and tell the staff that this was a good thing," explained former WEAU-13 news director Glen Mabie. Mabie resigned from the northwest Wisconsin television station "because of a disagreement ...

No
Posted by Diane Farsetta on January 11, 2008

The U.S. Congress is investigating "the pharmaceutical industry's use of celebrity endorsements in direct-to-consumer (DTC) advertisements." First up are ads for Pfizer's cholesterol drug Lipitor, which feature the inventor of the artificial heart, Dr. Robert Jarvik.

No
Posted by Judith Siers-Poisson on January 09, 2008

Open pill blister packThe pharmaceutical industry often uses the need for research and development funds as an excuse for exorbitant drug prices. But a new study by Marc-Andre Gagnon and Dr.

No

Pages

Subscribe to Science

Bill Moyers presents "United States of ALEC," a report on the most influential corporate-funded political force most of America has never heard of -- ALEC, the American Legislative Exchange Council.